Previous close | 51.58 |
Open | 51.58 |
Bid | 55.30 |
Ask | 57.65 |
Strike | 340.00 |
Expiry date | 2024-06-21 |
Day's range | 51.58 - 51.58 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Data from a late-stage study shows that treatment with Amgen's (AMGN) Uplizna achieves a statistically significant reduction in the risk of flares in patients with IgG4-RD, a rare disease.
Intra-Cellular (ITCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.